Sign in to continue:

Wednesday, April 8th, 2026

Author: Minichart

Ensysce Biosciences, Inc. Announces Director Resignation in April 2026 Form 8-K Filing

Ensysce Biosciences, Inc. - Form 8-K Report Analysis Ens...

Inflection Point Acquisition Corp. V Files 8-K and Amendment No. 2 to Promissory Note – April 2, 2026

Inflection Point Acquisition Corp. V Files 8-K: Amendment to...